Moreover, ketamine decreased the release of high-mobility group box 1, a late-phase cytokine of sepsis, in lipopolysaccharide-stimulated macrophages via activation of the Nrf2/HO-1 pathway and NF-κB suppression [139]. The gene discussed is NFE2L2; the disease is Sepsis.